Hollow superparamagnetic iron oxide nanoshells as a hydrophobic anticancer drug carrier: intracelluar pH-dependent drug release and enhanced cytotoxicity.

With curcumin and doxorubicin (DOX) base as model drugs, intracellular delivery of hydrophobic anticancer drugs by hollow structured superparamagnetic iron oxide (SPIO) nanoshells (hydrodynamic diameter: 191.9 ± 2.6 nm) was studied in glioblastoma U-87 MG cells. SPIO nanoshell-based encapsulation provided a stable aqueous dispersion of the curcumin. After the SPIO nanoshells were internalized by U-87 MG cells, they localized at the acidic compartments of endosomes and lysosomes. In endosome/lysosome-mimicking buffers with a pH of 4.5-5.5, pH-dependent drug release was observed from curcumin or DOX loaded SPIO nanoshells (curcumin/SPIO or DOX/SPIO). Compared with the free drug, the intracellular curcumin content delivered via curcumin/SPIO was 30 fold higher. Increased intracellular drug content for DOX base delivered via DOX/SPIO was also confirmed, along with a fast intracellular DOX release that was attributed to its protonation in the acidic environment. DOX/SPIO enhanced caspase-3 activity by twofold compared with free DOX base. The concentration that induced 50% cytotoxic effect (CC(50)) was 0.05 ± 0.03 μg ml(-1) for DOX/SPIO, while it was 0.13 ± 0.02 μg ml(-1) for free DOX base. These results suggested SPIO nanoshells might be a promising intracellular carrier for hydrophobic anticancer drugs.

[1]  In Su Lee,et al.  Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery. , 2009, Angewandte Chemie.

[2]  Xiaomin Zhu,et al.  Photocytotoxicity and magnetic relaxivity responses of dual-porous γ-Fe2O3@meso-SiO2 microspheres. , 2012, ACS applied materials & interfaces.

[3]  Abu T M Serajuddin,et al.  Salt formation to improve drug solubility. , 2007, Advanced drug delivery reviews.

[4]  Alfred Fahr,et al.  Drug delivery strategies for poorly water-soluble drugs: the industrial perspective , 2011, Expert opinion on drug delivery.

[5]  W. T. Beck,et al.  Quantitation of Doxorubicin Uptake, Efflux, and Modulation of Multidrug Resistance (MDR) in MDR Human Cancer Cells , 2008, Journal of Pharmacology and Experimental Therapeutics.

[6]  Yufang Zhu,et al.  Stimuli-responsive controlled drug release from a hollow mesoporous silica sphere/polyelectrolyte multilayer core-shell structure. , 2005, Angewandte Chemie.

[7]  Y. K. Agrawal,et al.  Nanosuspension: An approach to enhance solubility of drugs , 2011, Journal of advanced pharmaceutical technology & research.

[8]  R Weissleder,et al.  Superparamagnetic iron oxide: pharmacokinetics and toxicity. , 1989, AJR. American journal of roentgenology.

[9]  D. Zhao,et al.  Mesoporous biocompatible and acid-degradable magnetic colloidal nanocrystal clusters with sustainable stability and high hydrophobic drug loading capacity. , 2011, ACS nano.

[10]  M. Rahimi,et al.  Development of multiple-layer polymeric particles for targeted and controlled drug delivery. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[11]  Chen Guo,et al.  Adsorption and magnetic removal of neutral red dye from aqueous solution using Fe3O4 hollow nanospheres. , 2010, Journal of hazardous materials.

[12]  D. Gewirtz,et al.  Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. , 1994, Molecular pharmacology.

[13]  Xinglu Huang,et al.  Mesoporous magnetic hollow nanoparticles—protein carriers for lysosome escaping and cytosolic delivery , 2008, Nanotechnology.

[14]  Wei Cheng,et al.  One-step synthesis of superparamagnetic monodisperse porous Fe3O4 hollow and core-shell spheres , 2010 .

[15]  Hua Ai.  Layer-by-layer capsules for magnetic resonance imaging and drug delivery. , 2011, Advanced drug delivery reviews.

[16]  Jun Ren,et al.  Amidization of doxorubicin alleviates doxorubicin-induced contractile dysfunction and reduced survival in murine cardiomyocytes. , 2008, Toxicology letters.

[17]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[18]  J. Fréchet,et al.  pH-Responsive copolymer assemblies for controlled release of doxorubicin. , 2005, Bioconjugate chemistry.

[19]  X. Wu,et al.  A Mechanistic Study of Enhanced Doxorubicin Uptake and Retention in Multidrug Resistant Breast Cancer Cells Using a Polymer-Lipid Hybrid Nanoparticle System , 2006, Journal of Pharmacology and Experimental Therapeutics.

[20]  M. Mimeault,et al.  Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy , 2011, Chinese medicine.

[21]  J. Z. Hilt,et al.  Magnetic nanoparticles in biomedicine: synthesis, functionalization and applications. , 2010, Nanomedicine.

[22]  K. Leung,et al.  Biological and Magnetic Contrast Evaluation of Shape-Selective Mn–Fe Nanowires , 2009, IEEE Transactions on NanoBioscience.

[23]  K. Fung,et al.  Efficacy and Durability in Direct Labeling of Mesenchymal Stem Cells Using Ultrasmall Superparamagnetic Iron Oxide Nanoparticles with Organosilica, Dextran, and PEG Coatings , 2011, Materials.

[24]  Robert A Newman,et al.  Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.

[25]  D. Tomalia.  Interview: An architectural journey: from trees, dendrons/dendrimers to nanomedicine. Interview by Hannah Stanwix. , 2012, Nanomedicine.

[26]  Shouhu Xuan,et al.  Durable mesenchymal stem cell labelling by using polyhedral superparamagnetic iron oxide nanoparticles. , 2009, Chemistry.

[27]  Jinming Gao,et al.  Nanonization strategies for poorly water-soluble drugs. , 2011, Drug discovery today.

[28]  Monty Liong,et al.  Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. , 2008, ACS nano.

[29]  Bernadette Erokwu,et al.  Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice. , 2009, Biomaterials.

[30]  T. Skotland,et al.  In vitro stability analyses as a model for metabolism of ferromagnetic particles (Clariscan), a contrast agent for magnetic resonance imaging. , 2002, Journal of pharmaceutical and biomedical analysis.

[31]  A. Hampl,et al.  In vitro labelling of mouse embryonic stem cells with SPIO nanoparticles. , 2008, General physiology and biophysics.

[32]  J Verweij,et al.  Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. , 2001, European journal of cancer.

[33]  M. Gottesman,et al.  Targeting multidrug resistance in cancer , 2006, Nature Reviews Drug Discovery.

[34]  L. Gerace.  Molecular trafficking across the nuclear pore complex. , 1992 .

[35]  Mark Wilson,et al.  Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/ conventional angiography suite--initial experience with four patients. , 2004, Radiology.

[36]  Alex Sparreboom,et al.  Role of Formulation Vehicles in Taxane Pharmacology , 2001, Investigational New Drugs.

[37]  M. Dieci,et al.  Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer , 2012, Expert opinion on pharmacotherapy.

[38]  Zhongbing Huang,et al.  Preparation, structure, and magnetic properties of mesoporous magnetite hollow spheres. , 2005, Journal of colloid and interface science.

[39]  M. Spiteller,et al.  Structure and properties of camptothecin derivatives, their protonated forms, and model interaction with the topoisomerase I-DNA complex. , 2012, Biopolymers.

[40]  H. Ueno,et al.  Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin , 2004, British Journal of Cancer.

[41]  J. Eriksson,et al.  Targeted intracellular delivery of hydrophobic agents using mesoporous hybrid silica nanoparticles as carrier systems. , 2009, Nano letters.

[42]  Monty Liong,et al.  Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. , 2007, Small.

[43]  T. Fan,et al.  Caspase family proteases and apoptosis. , 2005, Acta biochimica et biophysica Sinica.

[44]  J. Verweij,et al.  Pharmacological Effects of Formulation Vehicles , 2003, Clinical pharmacokinetics.

[45]  Y. Zhan,et al.  Degradable poly(beta-amino ester) nanoparticles for cancer cytoplasmic drug delivery. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[46]  A. Ahuja,et al.  Enhanced cellular uptake of aminosilane-coated superparamagnetic iron oxide nanoparticles in mammalian cell lines , 2012, International journal of nanomedicine.

[47]  S. Hussain,et al.  Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging , 2001, European Radiology.

[48]  Duxin Sun,et al.  Superparamagnetic iron oxide nanotheranostics for targeted cancer cell imaging and pH-dependent intracellular drug release. , 2010, Molecular pharmaceutics.

[49]  Bobbi K Lewis,et al.  A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging , 2005, NMR in biomedicine.

[50]  Chun Wang,et al.  Block copolymer micelles with acid-labile ortho ester side-chains: Synthesis, characterization, and enhanced drug delivery to human glioma cells. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[51]  A. Ahuja,et al.  Low‐intensity pulsed ultrasound increases cellular uptake of superparamagnetic iron oxide nanomaterial: Results from human osteosarcoma cell line U2OS , 2010, Journal of magnetic resonance imaging : JMRI.

[52]  H Akita,et al.  Quantitative three-dimensional analysis of the intracellular trafficking of plasmid DNA transfected by a nonviral gene delivery system using confocal laser scanning microscopy. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[53]  Yu Chen,et al.  Core/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery. , 2010, ACS nano.

[54]  Linqi Shi,et al.  A multifunctional nanocarrier based on nanogated mesoporous silica for enhanced tumor-specific uptake and intracellular delivery. , 2012, Macromolecular bioscience.

[55]  Jimmy C. Yu,et al.  Synthesis of biocompatible, mesoporous Fe(3)O(4) nano/microspheres with large surface area for magnetic resonance imaging and therapeutic applications. , 2011, ACS applied materials & interfaces.

[56]  Shaobing Zhou,et al.  Magnetic micelles as a potential platform for dual targeted drug delivery in cancer therapy. , 2012, International journal of pharmaceutics.

[57]  T. Stinchcombe,et al.  Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxel. , 2007, Nanomedicine.

[58]  B. Strukelj,et al.  Recent Advances in Protection against Doxorubicin-induced Toxicity , 2008, Technology in cancer research & treatment.

[59]  F. Petrat,et al.  The Chelatable Iron Pool in Living Cells: A Methodically Defined Quantity , 2002, Biological chemistry.

[60]  B. Kwak,et al.  In vivo Tracking of Mesenchymal Stem Cells Labeled with a Novel Chitosan-coated Superparamagnetic Iron Oxide Nanoparticles using 3.0T MRI , 2010, Journal of Korean medical science.

[61]  S. Nie,et al.  Therapeutic Nanoparticles for Drug Delivery in Cancer Types of Nanoparticles Used as Drug Delivery Systems , 2022 .

[62]  Robert Langer,et al.  The biocompatibility of mesoporous silicates. , 2008, Biomaterials.

[63]  Jiwei Cui,et al.  Encapsulation of Water‐Insoluble Drugs in Polymer Capsules Prepared Using Mesoporous Silica Templates for Intracellular Drug Delivery , 2010, Advanced materials.

[64]  T. Okano,et al.  Development of the polymer micelle carrier system for doxorubicin. , 2001, Journal of controlled release : official journal of the Controlled Release Society.